Atossa Therapeutics ATOS
NASDAQ ATOS
$2.21 +0.08 (+3.76%)
As of: Nov 10, 2026 · 3:28 PM EST

Atossa Therapeutics (ATOS) Operating Leases (2019 - 2020)

Updated

Atossa Therapeutics (ATOS) posted Operating Leases of $1,217 for Q3 2020, down 91.3% from $14,018 a year earlier and down 74.2% from the prior quarter.

Analysis

Atossa Therapeutics (ATOS) Operating Leases (2019 - 2020) Analysis & Trends

At the end of FY2019, Atossa Therapeutics' Operating Leases came in at $11,108.

  • On a year-over-year basis, Operating Leases has declined in each of the last three quarters.
  • According to Business Quant data, Operating Leases for the three prior quarters was $4,720 (Q2 2020), $8,013 (Q1 2020) and $11,108 (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Atossa Therapeutics 19.96 Mn -131.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 1,217.00
Jun 30, 2020 4,720.00
Mar 31, 2020 8,013.00
Dec 31, 2019 11,108.00
Sep 30, 2019 14,018.00
Jun 30, 2019 24,027.00
Mar 31, 2019 37,397.00
API Access

Atossa Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ATOS&period=max&api_key=YOUR_API_KEY